Reporter Sept 26 2014
-
Optical imaging in drug therapy screens
A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients. Read MoreOct 1, 2014
-
Seizure mutation impairs receptor
Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures. Read MoreSep 30, 2014
-
Biomarker for diabetic eye disease
A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read MoreSep 26, 2014
-
A path to sarcoidosis treatment
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis. Read MoreSep 25, 2014
-
VUMC well positioned to move forward: Balser
Jeff Balser, M.D., Ph.D., delivers Tuesday’s State of the Medical Center Address in Langford Auditorium. (photo by Joe Howell) He began with a simple thank you. That’s how Jeff Balser, M.D., Ph.D., Vanderbilt’s vice chancellor for Health Affairs and dean of the School of Medicine chose to… Read MoreSep 25, 2014
-
Elevate town hall series kicks off Sept. 30
Beginning Tuesday, Sept. 30, members of Vanderbilt University Medical Center’s leadership team will hold a series of 45-minute town hall presentations that all faculty and staff are encouraged to attend. Read MoreSep 25, 2014
-
Bradfords’ strong support bolsters melanoma research
When something attacks you, you want to attack it back. That’s how Lillian “Tooty” Bradford views her late husband James “Jimmy” Bradford Jr.’s decision to make an initial gift to fund melanoma research at Vanderbilt-Ingram Cancer Center (VICC). Read MoreSep 25, 2014
-
Annual Flulapalooza event happens Oct. 1
Less than 10 seconds — that’s all it takes to roll up your sleeve and be part of next week’s Flulapalooza, Vanderbilt University Medical Center’s mass flu vaccination event that three years ago more than doubled the world record for the total number of vaccinations given in an eight-hour period. Read MoreSep 25, 2014
-
Cancer progress report calls for added research support
There are now approximately 14.5 million cancer survivors in the United States, thanks in large part to advances in cancer research and the development of new anti-cancer therapies. Read MoreSep 25, 2014
-
Churchwell to depart VHVI; Clair to assume interim role
Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1. Read MoreSep 25, 2014
-
Doherty set for next Discovery Lecture
Nobel laureate Peter Doherty, Ph.D., who discovered how the immune system recognizes virus-infected cells, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 2. Read MoreSep 25, 2014
-
Orthopaedic programs honored
Vanderbilt Orthopaedics has been named in the Becker’s Hospital Review list of 125 Hospitals and Health Systems With Great Orthopedic Programs. Read MoreSep 25, 2014
-
Student-run Shade Tree Clinic debuts ophthalmology service
When the Shade Tree Clinic first opened its doors in 2005 the patients received primary care services in the compact space of a cramped doublewide trailer. Read MoreSep 25, 2014
-
VUSN lecturer shares keys to successful negotiations
Ron Shapiro, negotiator, sports agent, attorney, educator, author and civic leader, recently led a workshop titled “How to Negotiate so Everyone Wins, Especially You!” at Vanderbilt University School of Nursing. Read MoreSep 25, 2014
-
Alexander’s visit highlights efforts to confront Ebola
Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee. Read MoreSep 24, 2014
-
Study finds accuracy of lung cancer imaging varies by region
A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common. Read MoreSep 24, 2014